AlloX
ALLOX develops a genetics- and AI-driven platform to discover and exploit allosteric sites for new drug design in oncology.
$10.5M Seed ·
Led by CDTI Innovación's INNVIERTE program · Source: tech.eu
All 2 rounds ↓Signals
AlloX | 1139 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $10.5M | tech.eu | ||
| Seed | undisclosed | — | — |
Timeline
- Website created
- X account created
Founders and team
JD
Júlia Domingo CEO & co-founder@JuliaDiumenge · source: allox.bioAF
BL
PB
Pablo Baeza Chief Discovery Officer & co-founder@pbcenturion · source: allox.bio
Investors
Other companies backed by CDTI Innovación's INNVIERTE program
OOna Therapeutics$86.6M Series B+ · Oct 2026
XXoople$130M Series B+ · Apr 2026
NNanoligent$14.01M Seed · Oct 2025
CDTI Innovación's INNVIERTE program portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/allox (get a free API key).